Navigation Links
Cell Signaling Technology Explores Mechanisms of Myeloid Immunosuppression in Educational Webinar
Date:9/27/2018

Infiltrating myeloid cells constitute a significant component of the suppressive tumor microenvironment (TME) and possibly contribute to therapeutic failures. An understanding of the immune regulatory context of the TME is required to harness the power of the antitumor immune response. In this webinar, which is sponsored by Cell Signaling Technology, attendees will learn of new solutions to better understand the TME in a context-dependent manner.

Using highly validated antibodies, immunohistochemical (IHC) techniques were employed in a 7-color TSA-based multiplex panel along with single- and dual-plex chromogenic stains to visualize biomarker expression in an array of tumor types. Newly validated Arginase1 and IDO1 monoclonal antibodies add a functional readout of the immunosuppressive TME to phenotypic marker analysis.

The speaker for this event will be Christopher Grange, an IHC specialist with Cell Signaling Technology. Grange has nearly 10 years of experience working with a variety of IHC techniques and technologies. His main focus over this time has been the development and validation of IHC-grade antibodies in a number of research areas. The main area of focus has been immuno-oncology, where he has developed automated IHC assays for novel I/O targets and provided support for multiple preclinical programs.

LabRoots will host the webinar on October 3, 2018, beginning at 9 a.m. PDT, noon EDT. To learn more about this event, discover the continuing education credits offered, or to register for free, click here.

About Cell Signaling Technology
Cell Signaling Technology is a private, family owned company, founded by scientists and dedicated to providing high-quality research tools to the biomedical research community. The company’s employees operate worldwide from its US headquarters in Massachusetts and offices in the Netherlands, China, and Japan.

About LabRoots
LabRoots is the leading scientific social networking website, which provides daily scientific trending news, as well as produces educational virtual events and webinars, on the latest discoveries and advancements in science. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning, and is a primary source for current scientific news, webinars, virtual conferences, and more. LabRoots has grown into the world’s largest series of virtual events within the Life Sciences and Clinical Diagnostics community.

Read the full story at https://www.prweb.com/releases/cell_signaling_technology_explores_mechanisms_of_myeloid_immunosuppression_in_educational_webinar/prweb15786345.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. Memorial Sloan-Kettering researchers develop new method for tracking cell signaling
2. Scientists construct visual of intracellular zip code signaling linked to learning, memory
3. New book on Signaling by Receptor Tyrosine Kinases by Cold Spring Harbor Laboratory Press
4. mTOR: A key brain signaling mechanism for rapidly acting antidepressants
5. Methylation signaling controls angiogenesis and cancer growth
6. Scientists solve 40-year mystery of how sodium controls opioid brain signaling
7. FASEB announces 2014 SRC: Protein Phosphorylation, Cellular Plasticity & Signaling Rewiring
8. FASEB announces 2014 Science Research Conference: Nutrient Sensing and Metabolic Signaling
9. FASEB announces 2014 SRC: Phospholipid Cell Signaling & Metabolism in Inflammation & Cancer
10. Newly discovered signaling pathway could impact a variety of autoinflammatory diseases
11. Geniposide protects hippocampal neurons via the non-classical estrogen signaling pathway
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/3/2018)... ... October 03, 2018 , ... Orbsen ... first-in-class stromal cell immunotherapies, announced that ORBCEL-M™, a second generation stromal cell ... progressive diabetic kidney disease in a four-site, pan-European Phase I/II clinical trial. ...
(Date:10/2/2018)... ... 2018 , ... Stuart is a fun-loving eight-year-old Labrador retriever. Like many labs, Stuart’s favorite ... loves playing ball so much that whenever anyone comes to our door, he grabs a ... fetch.” In early 2017, Stuart began limping and eventually could no longer play fetch. ...
(Date:10/2/2018)... ... October 02, 2018 , ... The ... 27th, 2018 at Tampa Convention Center. The Palo Alto-based face recognition company, Camvi ... on September 27th. Other speakers included U.S. Federal executives from Department of Defense ...
Breaking Biology News(10 mins):
(Date:9/27/2018)... EWING, N.J. (PRWEB) , ... September 26, 2018 ... ... and DNA testing are way ahead of their primary care physicians, according to ... , For this study, patients and doctors were asked about consumer adoption of ...
(Date:9/27/2018)... ... September 27, 2018 , ... This past weekend ... SureAdhere Mobile Technology, Inc. announced they will formally merge companies and integrate their ... tuberculosis (TB) and other diseases. These two social enterprise corporations, both of which ...
(Date:9/22/2018)... (PRWEB) , ... September 20, ... ... are excited to announce a strategic venture. The synergistic combination of Predicine’s ... provides complimentary and comprehensive biomarker profiling to empower clinical trials in the ...
(Date:9/15/2018)... ... September 14, 2018 , ... Next-generation genomic sequencing is transforming ... new technologies, challenges remain. In the past, the sheer size of genomics data has ... is a new data ecosystem developed to advance cures by reducing the technological barriers ...
Breaking Biology Technology: